Home/Directory/Digital Health & DTx/MEMOTEXT

MEMOTEXT

Toronto, ON · Canada

Digital Health & DTxsmall

Specialization: Digital patient engagement and adherence programs

Key Differentiator

Builds evidence-backed adherence and engagement programs, with more than 25 peer-reviewed publications behind its work.

Core Services

Conversational patient engagement platform; Medication adherence programs; Licensed program marketplace; mtxt.ai prototype validation and deployment; Outcomes evaluation

Capabilities

Medication adherence messagingConversational digital interventionsProgram co development and licensingOutcomes measurementHIPAA and PHIPA compliant hosting

Market Intelligence

Toronto company working since 2012 with researchers, health systems and commercial teams. Formed an adherence alliance with STI Technologies in 2015.

Website

www.memotext.com

Similar Companies

Think Research

Toronto, ON · Clinical Decision Support

TSX: THNK; Canadian digital health company serving 400+ hospitals/healthcare organizations; clinical decision support for drug safety and prescribing

Winterlight Labs

Toronto, ON · Speech-based digital biomarkers for clinical trials

Analyzes short speech samples to measure cognitive and mood changes in clinical trials.

Click Therapeutics

New York, NY · Prescription digital therapeutics

Co-develops FDA-cleared software treatments with pharma partners, such as Rejoyn with Otsuka.

Koneksa Health

New York, NY · Digital biomarkers and remote monitoring for trials

Builds digital biomarkers from remote data, such as its Parkinson's study that Merck and Regeneron joined through a data syndication program.

Need help finding the right outsourcing partner?

Try AI Navigator

Company information is sourced from publicly available data and may not be current. PharmoniQ does not endorse any company listed. Contact companies directly for the most up-to-date information.